AuntMinnieEurope

Conference hall with attendees seated facing a large blue projection screen displaying Vienna event branding and architectural imagery

EANM: AI studies target tumor boards, PET/CT protocoling, and PD-L1 prediction

A multi-agent AI system improved tumor board recommendations, while other studies explored PET/CT protocol selection and cancer biomarker prediction at EANM 2026 in Vienna.

Featured

Woman wearing glasses and gray blazer speaking at a microphone during a professional conference or event

Video from EANM: President Erba on radiopharmaceuticals, PET, and AI

Panel discussion at ISTAT26 conference in Vienna with speaker presenting on stage while seated panelists listen

EANM 2026: How early is early enough in prevention?

Patient relaxing inside an MRI scanner with illuminated circular ring during medical imaging procedure

Kaiser score outperforms MRI BI-RADS for inconclusive breast findings

October 20, 2026

A26 NMM World Leading Meeting event branding overlay on aerial city skyline at sunset

EANM: New PET tracer shows promise in kidney cancer

October 20, 2026

Clinical research presentation slide showing FAP RLT experience data table with patient outcomes across multiple institutions and speaker photo

EANM: Thomas Hope on what’s next in FAP-targeted theranostics

October 19, 2026

PET scan comparison showing SAFOV baseline and 1-minute and 5-minute time-point imaging with tracer uptake patterns

EANM: Next-generation PET scanner cuts imaging time to one minute

October 18, 2026

Check out our Cases of the Week!

0-day-old neonate with failure to thrive revisited

A 0-day-old neonate, born at 37 weeks and 6 days, with failure to thrive.

19-year-old man with lower abdominal pain revisited

60-year-old woman with multiple incidental peritoneal nodules

Patient relaxing inside an MRI scanner with illuminated circular ring during medical imaging procedure

Kaiser score outperforms MRI BI-RADS for inconclusive breast findings

EANM: AI studies target tumor boards, PET/CT protocoling, and PD-L1 prediction

EANM: New PET tracer shows promise in kidney cancer

EANM 2026 opened with Nobel lessons and waltz

Video from EANM: President Erba on radiopharmaceuticals, PET, and AI

Professional man in navy blazer smiling at conference event wearing ID badge

neuroRAD video: Joe Lennerz on continuous evidence tracking in medical AI

JFR: How to integrate AI in emergency imaging

AI leads to lower turnaround times for high-volume imaging

ESHNR heads to Budapest with dental imaging, cancer updates and AI on the agenda

Video: Charles Kahn on keeping pace with radiology AI

Brainomix highlights CT study using e-Lung software

GEHC begins global clinical evaluation of StarGuide GX SPECT/CT

Optellum integrates lung nodule AI with RapidAI platform

EANM: Affibody presents data on HER2 radioligand therapy

EANM: Akiram presents first clinical data for CD44v6-targeted therapy

Brainomix highlights CT study using e-Lung software

By AuntMinnie.com staff writers

The study showed how CT measures from the company's e-Lung tool found progression of pulmonary fibrosis before clinical diagnosis.

October 20, 2026

GEHC begins global clinical evaluation of StarGuide GX SPECT/CT

By AuntMinnie.com staff writers

Participating sites include health centers in the U.S., Europe, and Asia.

October 20, 2026

GE HealthCare CT scanner with gray housing, purple accent ring, and sliding patient table

Goyen's new book explores the emotional toll of caring for others

By Claudia Tschabuschnig

In his newly published book Who Holds the Doctor?, radiologist Prof. Dr. Mathias Goyen explores the emotional toll of caring for others and the pressures physicians face in clinical practice.

October 20, 2026

Book cover for 'Who Holds the Doctor?' by Mathias Goyen, MD, featuring a medical reflex hammer

Optellum integrates lung nodule AI with RapidAI platform

By AuntMinnie.com staff writers

The Virtual Nodule Clinic includes Patient Discovery AI and workflow tools for patient tracking and follow-up.

October 20, 2026

EANM: Lu-177 edotreotide dose linked to tumor response

By AuntMinnieEurope.com staff writers

Objective response rates climbed from 12% in the lowest dose quartile to 64% in the highest.

October 20, 2026

A26 NMM World Leading Meeting event branding displayed over an aerial cityscape at sunset

EANM 2026 opened with Nobel lessons and waltz

By Claudia Tschabuschnig

The opening ceremony of EANM 2026 combined scientific inspiration with a Viennese waltz.

October 19, 2026

Formal event on stage with elegantly dressed guests and musicians performing on large screen display above

EANM: Affibody presents data on HER2 radioligand therapy

By AuntMinnieEurope.com staff writers

The Stockholm, Sweden-based company is highlighting progress across its radiopharmaceutical pipeline.

October 19, 2026

A26 NMM World Leading Meeting event branding overlaid on aerial cityscape at sunset

EANM: Akiram presents first clinical data for CD44v6-targeted therapy

By AuntMinnieEurope.com staff writers

The first-in-human ongoing phase I trial is evaluating Lu-177 AKIR001 in patients with irresectable or metastatic CD44v6-positive solid tumors.

October 19, 2026

A26 NMM World Leading Meeting event branding overlaid on aerial cityscape at sunset

GE HealthCare expands ultrasound portfolio

By AuntMinnie.com staff writers

The new system is built on the company’s cSound Architecture with speckle reduction imaging.

October 19, 2026

GE Healthcare ultrasound system with display monitor showing cardiac imaging and control panel on mobile cart

Nuclidium, NorthStar sign Cu-67 supply and manufacturing deal

By AuntMinnie.com staff writers

Cu-67 is the therapeutic half of Nuclidium’s theranostic platform, which pairs it with copper-61 (Cu-61) for diagnostic imaging.

October 19, 2026

Hand holding glowing atom symbol with blue and gold light effects against blurred tech background

VR boosts accuracy, confidence for evaluating abdominal neuroblastoma

By Amerigo Allegretto

Compared with CT, VR helps surgeons more with anatomical assessment in abdominal neuroblastoma.

October 16, 2026

Medical CT scan visualization showing coronal, sagittal, and axial views with 3D organ segmentation including kidney, liver, aorta, and tumor models.

René Chapot challenges measures of success in distal thrombectomy

By Claudia Tschabuschnig

At neuroRAD 2026 in Mainz, Prof. Dr. René Chapot questioned in a video interview how success in distal thrombectomy is measured and explored the future of neurointervention.

October 16, 2026

Professional man in dark suit at medical conference with Ultravist product display in background